Metabolic Syndrome: Clinical Trials

2,098 trials for Metabolic Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1286 completed, 362 unknown, 184 recruiting, 75 not yet recruiting. 1170 Not applicable, 166 Phase 2, 139 Phase 4, 106 Phase 3, 52 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable1170Completed 762, Unknown 169, Recruiting 100, Active not recruiting 39, Not yet recruiting 32, Terminated 28, Withdrawn 20, Enrolling by invitation 13, Suspended 7
Phase 2166Completed 124, Recruiting 13, Terminated 11, Unknown 10, Withdrawn 5, Not yet recruiting 3
Phase 4139Completed 86, Unknown 25, Terminated 13, Recruiting 9, Not yet recruiting 4, Enrolling by invitation 1, Withdrawn 1
Phase 3106Completed 73, Unknown 14, Terminated 7, Not yet recruiting 4, Recruiting 3, Enrolling by invitation 2, Active not recruiting 1, Suspended 1, Withdrawn 1
Phase 152Completed 38, Recruiting 5, Unknown 5, Terminated 3, Withdrawn 1
Early Phase 121Completed 12, Unknown 3, Not yet recruiting 2, Recruiting 2, Enrolling by invitation 1, Terminated 1

Follow Metabolic Syndrome: new trials by email Literature Review of Metabolic Syndrome trials Research Report on Metabolic Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Postpartum Semaglutide to Reduce Cardiometabolic Risk After Gestational Diabetes Mellitus
Semaglutide (Wegovy) weekly injection - Gestational Diabetes Mellitus (GDM), Metabolic Syndrome
Phase 2 / Phase 3Not yet recruitingUniversity of Massachusetts, Worcester2262027-09-012026-09-28
Assessing Trauma-related Links Between Affective and Metabolic Systems
prazosin - Posttraumatic Stress Disorder, Metabolic Syndrome
Phase 4Not yet recruitingVA Office of Research and Development702027-03-012026-10-15
Efficacy and Safety of Semaglutide Versus Placebo on Cardiometabolic Profile in Patients With Schizophrenia With Metabolic Syndrome
Semaglutide + TAU, Placebo + TAU - Schizophrenia Disorder, Metabolic Syndrome
Phase 3Not yet recruitingAll India Institute of Medical Sciences, Bhubaneswar6002026-12-012026-08-18
Fecal Microbiota Transplantation (FMT) to Slow Biological Aging
Fecal microbiota transplantation delivery through oral capsules (HBI MBiotix Caps), PLACEBO for Fecal microbiota delivery through oral capsules - Aging, Healthy, Aging and Cognitive Health
Not applicableNot yet recruitingHuman Biome S.A.682026-12-012026-11-03
Alpha-Lipoic Acid Added to Dapagliflozin and Insulin Resistance in Type 2 Diabetes
Alpha-Lipoic Acid (ALA), Placebo - Diabetes Mellitus, Type 2, Insulin Resistance Syndrome
Phase 3Not yet recruitingFayoum University702026-12-012026-11-12
Effects of Meal Macronutrients on Postprandial Lipids
High carb then high fat breakfast, High fat then high carb breakfast - Nephrotic Syndrome, Lipodystrophy
Phase 2Not yet recruitingNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1002026-11-182026-11-13
Fulvic Acid Supplementation and Metabolic Syndrome
fulvic acid, Placebo - Metabolic Syndrome
Not applicableRecruitingArizona State University602026-11-062026-11-10
Metabolic Surgery for Atrial Fibrillation Elimination
Roux-en-Y Gastric Bypass or Sleeve Gastrectomy, Anti-Obesity Medication (AOM) treatment - Atrial Fibrillation, Obesity and Obesity-related Medical Conditions
Phase 4Not yet recruitingAli Aminian1002026-11-012026-04-17
Asprosin and miRNA Expression in Young Women With Metabolic Syndrome
Biomarker panel (asprosin, microRNA, BDNF, cortisol), Clinical and questionnaire assessment - Metabolic Syndrome, Insulin Resistance
RecruitingUniversity of Applied Sciences in Nowy Targ1102026-11-012026-11-04
Human Cerebrovascular Blood Flow and Sex Differences in Metabolic Syndrome
Indomethacin, Placebo, MRI - Metabolic Syndrome
Early Phase 1Not yet recruitingUniversity of Wisconsin, Madison722026-11-012026-11-02
Lifestyle Changes, Mushroom Supplementation, and Bupropion to Reduce Adiposity and Cardiometabolic Risk
Bupropion 150 mg, Lyophilized powder from edible mushrooms, Lifestyle Management - Cardiometabolic Syndrome, Obesity and Cardiovascular Risk
Phase 3Not yet recruitingUppsala University2502026-10-302026-09-08
Pilot Study of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI)
Galantamine Hydrobromide Extended Release - Spinal Cord Injury, Traumatic Spinal Cord Injury
Phase 2 / Phase 3RecruitingNorthwell Health602026-10-152026-11-04
Preoperative Oral Carbohydrate Loading and Gastrointestinal Recovery After Bariatric Surgery in Metabolic Syndrome
Preoperative oral carbohydrate loading, The placebo - Metabolic Syndrome (MetS)
Not applicableRecruitingFirst Affiliated Hospital of Chongqing Medical University2082026-10-082026-10-15
Serum Asprosin, Metabolic Syndrome, and Cardiometabolic Risk in Rheumatoid Arthritis
Rheumatoid Arthritis, Metabolic Syndrome
Not yet recruitingAssiut University752026-10-012026-08-31
Creatinine-Body Weight Ratio as a Predictor of Hepatic Steatosis in Patients With Metabolic Syndrome
Metabolic Syndrome (MetS)
Not yet recruitingAssiut University962026-10-012026-08-21
Associations Between Dietary Patterns, LDL Aggregation, and Cardiometabolic Health
Atherosclerosis Cardiovascular Disease, Metabolic Syndrome
Not yet recruitingLiverpool John Moores University902026-10-012026-08-26
Therapeutic Strategies to Reduce Endothelial Ischemia-reperfusion Injury
Ischemic preconditioning, Intravenous lactate infusion, No ischemic preconditioning (control) - Metabolic Syndrome, Vascular Injury
Early Phase 1Not yet recruitingGary Van Guilder682026-10-012025-02-13
Targeted Health Dialogues for Individuals With Psychosis Spectrum Disorders
Targeted Health Dialogues - Psychoses, Metabolic Syndrome
Not applicableNot yet recruitingUppsala University602026-10-012026-10-22
Effectiveness of the Personalized Responses & Integrated Systems for Metabolism (PRISM) on Improving Insulin Resistance Among Adults With Metabolic Syndrome: A Pilot Study (PRISM-I)
Time-restricted eating, Physical Activity, Low Glycemic Load diet - Metabolic Syndrome (MetS)
Not applicableRecruitingNational University Health System, Singapore2002026-09-172026-09-25
Mazdutide for Weight Management and Gout in Adults With Obesity
Mazdutide - Gout, Obesity (BMI>30)
Phase 4Not yet recruitingHongwei Jiang302026-09-152026-09-17

Showing 20 of 2098. Sign in to see all of them.

Narrower conditions

Obesity (614)  ·  Insulin Resistance (321)  ·  Diabetes Mellitus (215)  ·  Hypertension (198)  ·  Cardiovascular Diseases (192)  ·  Overweight (179)  ·  Diabetes Mellitus, Type 2 (173)  ·  Motor Activity (141)  ·  Inflammation (124)  ·  Dyslipidemias (116)  ·  Non-alcoholic Fatty Liver Disease (92)  ·  Weight Loss (78)  ·  Prediabetic State (69)  ·  Glucose Intolerance (68)

Broader conditions

Nutritional and Metabolic Diseases (2092)  ·  Hyperinsulinism (2089)  ·  Glucose Metabolism Disorders (2083)  ·  Metabolic Diseases (2057)  ·  Insulin Resistance (1777)  ·  Pathological Conditions, Signs and Symptoms (953)  ·  Signs and Symptoms (813)  ·  Nutrition Disorders (736)  ·  Body Weight (735)  ·  Overnutrition (730)  ·  Overweight (554)  ·  Endocrine System Diseases (471)  ·  Vascular Diseases (295)  ·  Cardiovascular Diseases (264)  ·  Pathologic Processes (246)

Interventions

Exercise (85)  ·  Metformin (46)  ·  Diet (38)  ·  Diet, Mediterranean (19)  ·  Bariatric Surgery (16)  ·  Pioglitazone (16)  ·  Fish Oils (15)  ·  Blood Specimen Collection (14)  ·  Control Groups (14)  ·  Standard of Care (14)  ·  Atorvastatin (13)  ·  Diet Therapy (13)  ·  Resistance Training (13)  ·  Aripiprazole (12)  ·  Berberine (12)

Sponsors

Laval University (24)  ·  Cairo University (20)  ·  University of Copenhagen (20)  ·  University of Toronto (17)  ·  National Taiwan University Hospital (16)  ·  Lund University (14)  ·  Massachusetts General Hospital (14)  ·  University of Aarhus (14)  ·  Assistance Publique - Hôpitaux de Paris (13)  ·  University of California, Davis (13)  ·  University of Guadalajara (13)  ·  Assiut University (12)  ·  University Hospital, Clermont-Ferrand (12)  ·  Stanford University (11)  ·  University of California, San Francisco (11)

Countries

United States (576)  ·  Canada (120)  ·  Italy (93)  ·  Spain (89)  ·  China (88)  ·  France (74)  ·  Denmark (73)  ·  Germany (71)  ·  Taiwan (68)  ·  South Korea (53)  ·  United Kingdom (53)  ·  Turkey (Türkiye) (52)  ·  Mexico (41)  ·  Netherlands (41)  ·  Egypt (39)

Top investigators

David JA Jenkins, MD, PhD, DSc (8)  ·  John L Sievenpiper, MD, PhD (7)  ·  Russell J de Souza, ScD, RD (7)  ·  Anne Nilsson, PhD (5)  ·  Cyril WC Kendall, PhD (5)  ·  Allison B. Goldfine, MD (4)  ·  Andreas Michalsen, Prof. Dr. (4)  ·  Kim F Michaelsen, Dr Med Sci (4)  ·  Kjeld Hermansen, Professor (4)  ·  Pam Taub, MD (4)  ·  Ali MA Ismail, lecturer (3)

Results publications

PMID 18820647, PMID 10480510, PMID 12485966, PMID 15572438, PMID 16183552, PMID 16338915, PMID 16636217, PMID 17443373, PMID 17666313, PMID 18175740, PMID 18305915, PMID 18557952, PMID 19723613, PMID 19805654, PMID 19889232, PMID 20024643, PMID 20208057, PMID 20826632, PMID 21070531, PMID 21694556, PMID 22090467, PMID 22990269, PMID 25091629, PMID 25590214, PMID 25904601, PMID 26297500, PMID 26511519, PMID 28408009, PMID 30089732, PMID 30256894, PMID 30459053, PMID 31004409, PMID 31217353, PMID 31384309, PMID 32275191, PMID 33210751, PMID 33293204, PMID 33512717, PMID 34091663, PMID 34986271, PMID 35565900, PMID 36262060, PMID 37364790, PMID 38375882, PMID 38851997, PMID 38958149, PMID 39641307, PMID 39963952, PMID 10022400, PMID 10199767

NIH funding

2005 (6), 2019 (3), 2008 (2), 2009 (2), 2014 (2), 2016 (2), P50HL083762 (2), P50HL083813 (2), R01AG018198 (2), R01DK049302 (2), R01MD017610 (2), U01DK074556 (2), 1IK2RX001651-01A2 (1), 2017 (1), 2023 (1)